Accretion Pha.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0T8T01010
  • NSEID: ACCPL
  • BSEID:
INR
89.00
-1.85 (-2.04%)
BSENSE

Dec 17

BSE+NSE Vol: 9600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 329.70% vs NA in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 363.55% vs NA in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 259.94% vs NA in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 355.08% vs NA in Mar 2024

Compare Profit and Loss Results of Accretion Pha.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
57.00
99.00
-42.00
-42.42%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
57.00
99.00
-42.00
-42.42%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-4.00
1.00
25.00%
Raw Materials Consumed
43.00
90.00
-47.00
-52.22%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
3.00
2.00
1.00
50.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2.00
-2.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
6.00
-6.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
45.00
98.00
-53.00
-54.08%
Operating Profit (PBDIT) excl Other Income
11.00
0.00
11.00
0%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
11.00
3.00
8.00
266.67%
Interest
1.00
1.00
0.00
0.00%
Profit before Depriciation and Tax
10.00
1.00
9.00
900.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
9.00
1.00
8.00
800.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
1.00
8.00
800.00%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
6.00
0.00
6.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
15.00
-14.00
-93.33%
Profit Available for appropriations
8.00
15.00
-7.00
-46.67%
Appropriations
8.00
15.00
-7.00
-46.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.48
0.06
8.42
14,033.33%
Profit And Loss - Net Sales
Net Sales 57.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 329.70% vs NA in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 363.55% vs NA in Mar 2024

Profit And Loss - Interest
Interest 1.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 259.94% vs NA in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 6.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 355.08% vs NA in Mar 2024